Medscape10d
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Carlsson ML; Martin P; Nilsson M; Sorensen SM; Carlsson A; Waters S; Waters N The purpose of the present study was to compare the effectiveness of the selective 5-HT2A antagonist M100907 in ...
pharmaphorum3d
Exscientia starts trials of AI-designed Alzheimer's drug
According to the partners, DSP-0038 combines serotonin 5-HT2A receptor antagonism and 5 ... avoids stimulating similar receptors, such as the dopamine D2 receptor, that can lead to unwanted ...